FDA approves new drug for hyperkalemia
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.